Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Oct 02, 2026
General Mills (GIS) Stock Declines -22% in 30 Days After Mixed Earnings and Leadership News

General Mills (GIS) Stock Declines -22% in 30 Days After Mixed Earnings and Leadership News

Key Takeaways

  • General Mills shares fell roughly 22% over the last 30 days, from about $40.58 to about $31.67, as investors absorbed a mixed fiscal 2027 first-quarter report and a reported CEO transition.
  • The September earnings release beat adjusted EPS and revenue estimates, but net sales still declined 3% year over year and management warned input-cost inflation could approach 6% by the fourth quarter.
  • News late in the month that COO Dana McNabb would succeed CEO Jeff Harmening added to investor uncertainty.
  • The decline extends a broader packaged-food downturn driven by cautious consumers, tariff and freight costs, and elevated interest rates.
  • Analyst opinion remains divided, with several firms holding Sell or Hold ratings and price targets in the low-to-mid $30s, while at least one reiterated an Outperform view.

General Mills (GIS) Business Snapshot and Competitive Landscape

General Mills stands as one of the largest branded food companies globally, with a broad portfolio that covers breakfast cereals, snacks, meals, baking items, pet food, and frozen products. Familiar names such as GIS include Cheerios, Pillsbury, Betty Crocker, Old El Paso, Nature Valley, Progresso, Green Giant, Wheaties, and the Blue Buffalo pet-food line. Operations break down mainly into North America Retail, North America Pet, North America Foodservice, and International segments, producing roughly $18 billion in fiscal 2026 net sales.

Many investors have long regarded GIS as a reliable defensive staples name with a steady dividend. Lately, though, persistent headwinds have included softer volumes in core areas like cereal, heavier promotional activity amid value-conscious shoppers, rising input costs, and portfolio adjustments that involved selling the U.S. and Canada yogurt businesses while deepening the pet-food focus. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

General Mills (GIS) Price Action: 30-Day Drop Versus Quarterly Moves

Over the most recent 30 days, GIS dropped approximately 22%, moving from a closing price near $40.58 down to roughly $31.67. The slide was fairly steady and concentrated in the second half of September after the earnings release and follow-on analyst commentary.

The quarterly view shows more nuance. From early July levels near $37.77, shares climbed into the low-$40s by late August before reversing and finishing near $31.67, for a quarterly decline of about 16%. Essentially, nearly all the damage occurred in September, highlighting how quickly sentiment shifted after the latest results. From what I see, this pattern underscores the market’s sensitivity to any signs of margin pressure in the staples space.

Drivers Behind the Recent 30-Day Decline in GIS

The main trigger was the fiscal 2027 first-quarter earnings report released in late September. Adjusted diluted EPS of $0.75 topped the $0.72 consensus, and revenue near $4.39 billion also exceeded expectations. Still, underlying softness showed through: net sales slipped 3% year over year, net earnings fell 67% to $397 million, and reported operating profit declined 63% to about $634 million, largely reflecting a prior-year gain of roughly $1.05 billion from the yogurt divestiture. Adjusted operating profit still dropped 11% in constant currency.

Management added further caution by noting that input-cost inflation, which ran near 4% in the quarter, could reach roughly 6% by the fourth quarter due to freight, grains, packaging, and Canadian tariffs. North America Retail sales fell 7% to $2.45 billion, and the company indicated it has not fully regained competitive position in several key categories. Analyst notes reinforced the pressure, with Wells Fargo keeping a Sell rating and $33 target while TD Cowen held at Hold but lifted its target from $32 to $33. RBC Capital Markets, however, reaffirmed an Outperform stance with a $45 target. Late-month reports that COO Dana McNabb would take over from CEO Jeff Harmening introduced extra uncertainty around the pace of any turnaround.

Quarterly Context and Longer-Term Reset Efforts at General Mills (GIS)

The broader quarterly trend ties into a multi-year effort to reposition the business. General Mills wrapped up its base-price investments in fiscal 2026 and has turned attention to innovation—higher-protein Cheerios, clean-label and bolder flavors, and premium pet-food options—while targeting at least $750 million in cost savings this fiscal year. Portfolio reshaping through divestitures and greater pet-food emphasis continues as well.

These steps have not yet produced sustained growth. Organic net sales guidance for fiscal 2027 calls for a range of down 1.5% to up 0.5%, adjusted operating profit is expected to decline 8% to 13% in constant currency, and leverage sits slightly above four times net debt-to-EBITDA, keeping investors on edge. Macro factors such as above-target inflation, higher interest rates, and a value-seeking consumer have weighed on the shares even as management highlighted sequential improvement in North American retail trends. I’m watching this closely for any signs that cost-saving initiatives are gaining traction.

Key Factors to Monitor for GIS Going Forward

Several elements will likely influence General Mills’ trajectory in the coming months. Investors will track whether North America Retail sales growth and market-share trends sustain their sequential improvement, and whether the innovation pipeline—renovations to Totino’s, Annie’s, and the Life Protection Formula pet brand, along with the Nature Pals fruit-snack launch—can restore volume. The path of input-cost inflation, expected to peak near 6% late in the fiscal year, will remain central to margin recovery.

Execution of the CEO transition and progress on the Wilderness dry-dog-food turnaround are additional items to follow, as is delivery of the $750 million cost-savings target and progress toward lower leverage. Broader macro conditions around interest rates, consumer spending, and tariff policy will continue to shape sentiment in the packaged-food group.

Using AI Tools in My Research Process

One resource I’ve turned to when evaluating names like this is Tickeron’s AI Trend Prediction Engine. It helps surface pattern-based signals and historical context that complement traditional fundamental work, giving a clearer view of how similar setups have played out in the past. I find it useful for cross-checking momentum and volatility expectations before forming a fuller picture.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: GIS

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


GIS in upward trend: price may jump up because it broke its lower Bollinger Band on September 30, 2026

GIS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 28 of 48 cases where GIS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 58%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where GIS advanced for three days, in 163 of 310 cases, the price rose further within the following month. The odds of a continued upward trend are 53%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GIS as a result. In 47 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 53%.

The Moving Average Convergence Divergence Histogram (MACD) for GIS turned negative on September 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 30 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.

GIS moved below its 50-day moving average on September 08, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for GIS crossed bearishly below the 50-day moving average on September 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 40%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GIS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.

The Aroon Indicator for GIS entered a downward trend on October 01, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.411) is normal, around the industry mean (5.422). P/E Ratio (9.235) is within average values for comparable stocks, (32.504). Projected Growth (PEG Ratio) (11.737) is also within normal values, averaging (8.458). GIS has a moderately high Dividend Yield (0.073) as compared to the industry average of (0.025). P/S Ratio (1.074) is also within normal values, averaging (4.925).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. GIS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 75 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GIS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are Kraft Heinz Company (The) (NYSE:KHC), General Mills (NYSE:GIS), The Campbell's Company (NASDAQ:CPB), Beyond Meat Inc. (NASDAQ:BYND).

Industry description

Companies in this industry usually make a diverse range of agricultural and/or processed food. Some prominent names in this segment are Mondelez International, which makes chocolates, biscuits, cookies etc. The Kraft Heinz Company specializes in ketchups, sauces, fruit drink pouches and many more. General Mills, Inc. sells flour and cereal. Kellogg is famous for its snacks and breakfast cereal. And so on down the line. As more and more consumers are looking for healthier options in food in recent years, several legacy food companies have responded by revamping brands to include organic and no-added-sugar versions, and/or acquiring healthy food firms, and even streamlining operations.

Market Cap

The average market capitalization across the Food: Major Diversified Industry is 2.9B. The market cap for tickers in the group ranges from 68.81K to 239.66B. NSRGY holds the highest valuation in this group at 239.66B. The lowest valued company is THRC at 68.81K.

High and low price notable news

The average weekly price growth across all stocks in the Food: Major Diversified Industry was -4%. For the same Industry, the average monthly price growth was -13%, and the average quarterly price growth was -16%. SMPL experienced the highest price growth at 5%, while STKH experienced the biggest fall at -56%.

Volume

The average weekly volume growth across all stocks in the Food: Major Diversified Industry was 40%. For the same stocks of the Industry, the average monthly volume growth was 52% and the average quarterly volume growth was 19%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 61
Price Growth Rating: 68
SMR Rating: 78
Profit Risk Rating: 93
Seasonality Score: 13 (-100 ... +100)
View a ticker or compare two or three
GIS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of consumer food products

Industry FoodMajorDiversified

Industry
Food Major Diversified
Address
Number One General Mills Boulevard
Phone
+1 763 764-7600
Employees
30000
Web
https://www.generalmills.com
Interact to see
Advertisement
MRSH stock declined approximately -9% over the past 30 days, driven by sector-wide AI disruption fears and analyst downgrades. Over the past quarter, the stock fell around -7%, amid softening insurance rates and declining fiduciary interest income.
MCO stock declined approximately -9% over the last 30 days amid profit-taking, insider selling, and sector-wide concerns in financial data analytics. Over the past quarter, shares fell around -18%, reflecting a correction from January highs despite strong Q4 2025 earnings. Key drivers include post-earnings selloff after Q4 results, analyst price target cuts, and broader market volatility in credit ratings sector.
SNOW stock declined approximately -9% over the last 30 days, from around $168 to $153, amid post-earnings profit-taking and analyst caution despite strong results. Over the past quarter, the stock fell about -31%, from near $223, reflecting broader sector pressures and valuation concerns in cloud software.
WDS stock surged +24% over the past 30 days, driven by a sharp rally in oil and LNG prices amid Middle East supply disruptions, including Strait of Hormuz issues and strikes on Qatar's Ras Laffan facility. Over the past quarter, the stock climbed +55%, reflecting sustained energy market volatility and Woodside's strong production from assets like Sangomar and Pluto LNG.
HMC stock declined -19% over the past 30 days amid major setbacks in EV strategy, including cancellation of North American EV models and up to $15.7 billion in related losses. Over the past quarter, shares fell -18%, driven by persistent auto segment weakness, tariff impacts, and revised FY2026 forecasts to a net loss. Key catalysts include March EV reassessment announcement causing a 5%+ drop, Q3 earnings beat overshadowed by one-time charges and guidance concerns, and Sony-Honda JV EV project halt.
EL stock plunged approximately -39% over the past 30 days amid merger discussions with Puig, tariff pressures, and restructuring costs, marking a highly volatile period. Over the past quarter, the stock is down around -37%, reflecting broader sector headwinds despite earlier quarterly earnings beats. Key drivers include confirmation of potential business combination with Puig sparking uncertainty, ongoing $100 million tariff impacts, and elevated restructuring expenses.
ESLT stock rose +13% over the past 30 days, driven primarily by a blowout Q4 2025 earnings report with revenue up 11% and EPS beating estimates by over 10%. Over the past quarter, shares surged +52%, fueled by a record $28.1 billion order backlog, up significantly year-over-year, amid heightened global defense demand. Geopolitical tensions in the Middle East boosted demand for Elbit's systems, alongside major contract wins totaling hundreds of millions from international clients.
EQT stock rose approximately +10% over the last 30 days, driven by strong Q4 2025 earnings beat, robust free cash flow guidance for 2026, and analyst price target increases. Over the past quarter, shares gained around +23%, fueled by operational efficiencies, natural gas price recovery, and positive sector sentiment amid LNG demand growth.
Robin Energy Ltd is a Cyprus-based shipping company focused on ocean and deep-sea freight transportation. As a holding entity, it acquires, owns, charters, and manages oceangoing tanker vessels worldwide. The core of its business lies in energy transportation services, mainly through handysize tankers and LPG carriers. In the competitive marine shipping industry, RBNE positions itself as a growth-oriented player, expanding its fleet and locking in multi-year charters. Recent developments, such as vessel acquisitions and Bitcoin treasury allocations, leave it exposed to shipping cycles and alternative asset volatility. From what I see, this mix contributes to the erratic stock price behavior we've observed amid shifting global energy demand and freight rates.
NG stock plunged -42% over the past 30 days amid sharp declines from mid-March peaks around $14, driven by profit-taking after a multi-year rally and sector-wide weakness in gold mining stocks. Over the past quarter, the stock is down -14%, reflecting volatility from early-year gains tied to financing successes offset by recent macro pressures and permitting concerns. Key drivers include gold price fluctuations due to interest rate expectations, profit-taking post-240%+ annual surge, and no immediate production revenue despite Donlin Gold project advancements.
CRBU stock declined approximately -10% over the past 30 days, reflecting volatility amid clinical updates and financing concerns. Over the past quarter, the stock rose about +12%, driven by positive earnings beats and pipeline progress. Key drivers include Q4 2025 earnings beat, vispa-cel Phase 3 plans, but offset by cash burn and need for additional capital.
Shares of Viridian Therapeutics (VRDN) are down approximately 32% in premarket trading on March 30, 2026, against a prior closing price of $27.39 on March 27, 2026, implying a premarket price near $18.63. The primary catalyst is the release of topline Phase 3 REVEAL-1 clinical trial data for elegrobart (VRDN-003) in patients with active thyroid eye disease (TED), long anticipated as the company's most critical near-term de-risking event.
SYY shares are trading approximately -6.40% lower in premarket trading on March 30, 2026, from a prior close of $81.80 to roughly $76.56. The primary catalyst is Sysco's announcement of a $29.1 billion definitive agreement to acquire Jetro Restaurant Depot, one of the nation's largest Cash & Carry food wholesalers.
Northwest Biotherapeutics, Inc. (NWBO) is a clinical-stage biotechnology company focused on developing personalized immune therapies, primarily dendritic cell-based vaccines under its DCVax platform. The company's lead candidate, DCVax-L, targets glioblastoma multiforme (GBM), a lethal brain cancer, following completion of a Phase III trial. DCVax-Direct addresses inoperable solid tumors, with Phase I/II data available. NWBO operates in the competitive immunotherapy sector against players like large-cap biotechs, relying on a proprietary manufacturing process for cost-effective production.
FingerMotion, Inc. (FNGR) operates as a mobile data specialist, delivering mobile payment and recharge platform solutions mainly in China. The company's core revolves around telecommunication products and services, such as top-up recharges, data plans, SMS and MMS services, big data insights for consumer behavior analysis, and rich communication services (RCS) platforms. It also provides value-added products through partnerships with telecom providers and e-commerce platforms.
NIO Inc. (NIO) stands out as a leading Chinese electric vehicle manufacturer focused on premium smart EVs. The company designs, develops, and sells high-end battery electric vehicles, bolstered by its Battery-as-a-Service model that lets customers swap batteries at stations rather than owning them. In the cutthroat Chinese EV space, NIO competes directly with firms like XPEV and LI.
Xcel Energy Inc. (XEL) stands out as a major U.S. electric and natural gas utility, serving about 3.7 million electric and 2.2 million natural gas customers across eight states, mainly in the Midwest and West. The company focuses on regulated utilities, handling electricity generation, transmission, and distribution, while increasingly prioritizing renewable sources like wind and solar. Its model centers on steady, regulated returns from infrastructure investments, backed by rate cases and recovery mechanisms.
Occidental Petroleum Corporation (OXY) stands out as a leading independent energy producer, with a primary focus on hydrocarbon exploration and production. The company has significant operations in the Permian Basin, one of the U.S.'s most productive oil regions, along with assets in the Rockies, Latin America, and the Middle East. Its business model emphasizes efficient drilling, low-cost production, and carbon capture initiatives aimed at long-term sustainability.
The ProShares UltraShort Bloomberg Natural Gas (KOLD) is a leveraged inverse exchange-traded fund that seeks daily investment results, before fees and expenses, corresponding to two times the inverse (-2x) of the daily performance of the Bloomberg Natural Gas Subindex. This subindex reflects the natural gas segment of the commodities market by tracking futures contracts, primarily the second-month Henry Hub natural gas futures, weighted by liquidity and production. The fund does not invest directly in physical natural gas but uses derivatives like futures contracts and swaps to achieve its objective.
Shares of United Therapeutics (UTHR) are surging approximately +17% in premarket trading on Monday, March 30, 2026, with the market not yet open. The primary catalyst is a landmark Phase 3 clinical trial announcement: the TETON-1 pivotal study of nebulized Tyvaso® (treprostinil) met its primary endpoint for treating idiopathic pulmonary fibrosis (IPF), exceeding the already impressive treatment effects seen in the previously completed TETON-2 study.